Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Blakey

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
European Clinical Respiratory Journal|May 5, 2017
Use of electronic medical records and biomarkers to manage risk and resource efficienciesDermot Ryan, John Blakey, Alison Chisholm, et al.
The Medical Journal of Australia|November 16, 2025
CURE Asthma: a unique opportunity for AustraliaAnthony Flynn, Wendy Edmondson, Alan James, et al.
Advances in Therapy|September 25, 2025
Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/Formoterol Fumarate in General Practice in EnglandAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|July 25, 2024
Predictive analytics for early detection of hospital-acquired complications: An artificial intelligence approachSyed Aqif Mukhtar, Benjamin R McFadden, Md Tauhidul Islam, et al.
Pulmonary Therapy|October 29, 2025
Correction: Real-world Comparative Effectiveness in Patients with Asthma Newly Initiating Fluticasone Furoate/Vilanterol or Budesonide/Formoterol: A United Kingdom General Practice Cohort StudyAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
Advances in Therapy|November 1, 2025
Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in EnglandAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
Pulmonary Therapy|September 16, 2025
Real-world Comparative Effectiveness in Patients with Asthma Newly Initiating Fluticasone Furoate/Vilanterol or Budesonide/Formoterol: A United Kingdom General Practice Cohort StudyAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
NPJ Primary Care Respiratory Medicine|February 16, 2026
Efficacy and safety of different inhaler types for asthma and chronic obstructive pulmonary disease. a systematic review and meta-analysisMichael J Loftus, Miranda S Cumpston, Shannon Barnes, et al.
The European Respiratory Journal|January 9, 2021
A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary careClare S Murray, Sarah J Lucas, John Blakey, et al.
Thorax|January 13, 2017
Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and WalesMichael C Steiner, Derek Lowe, Katy Beckford, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
European Clinical Respiratory Journal|May 5, 2017
Use of electronic medical records and biomarkers to manage risk and resource efficienciesDermot Ryan, John Blakey, Alison Chisholm, et al.
The Medical Journal of Australia|November 16, 2025
CURE Asthma: a unique opportunity for AustraliaAnthony Flynn, Wendy Edmondson, Alan James, et al.
Advances in Therapy|September 25, 2025
Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/Formoterol Fumarate in General Practice in EnglandAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|July 25, 2024
Predictive analytics for early detection of hospital-acquired complications: An artificial intelligence approachSyed Aqif Mukhtar, Benjamin R McFadden, Md Tauhidul Islam, et al.
Pulmonary Therapy|October 29, 2025
Correction: Real-world Comparative Effectiveness in Patients with Asthma Newly Initiating Fluticasone Furoate/Vilanterol or Budesonide/Formoterol: A United Kingdom General Practice Cohort StudyAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
Advances in Therapy|November 1, 2025
Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in EnglandAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
Pulmonary Therapy|September 16, 2025
Real-world Comparative Effectiveness in Patients with Asthma Newly Initiating Fluticasone Furoate/Vilanterol or Budesonide/Formoterol: A United Kingdom General Practice Cohort StudyAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
NPJ Primary Care Respiratory Medicine|February 16, 2026
Efficacy and safety of different inhaler types for asthma and chronic obstructive pulmonary disease. a systematic review and meta-analysisMichael J Loftus, Miranda S Cumpston, Shannon Barnes, et al.
The European Respiratory Journal|January 9, 2021
A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary careClare S Murray, Sarah J Lucas, John Blakey, et al.
Thorax|January 13, 2017
Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and WalesMichael C Steiner, Derek Lowe, Katy Beckford, et al.
Pageof 4